Advertisement
Screener

BIOATLA, INC. (BCAB) ROE

BIOATLA, INC. (BCAB) ROE

  • 2026-06-30: ROE 86.80%.
  • 2026-03-31: ROE 135.67%.
  • 2025-12-31: ROE 164.71%.
  • 2025-09-30: ROE 207.15%.

Complete source-backed roe history.

Available history
2019-12-31 to 2026-06-30
Data captured

Historical ROE

DateROE
2026-06-3086.80%
2026-03-31135.67%
2025-12-31164.71%
2025-09-30207.15%
2025-06-30355.42%
2025-03-31-11311.88%
2024-12-31-489.14%
2024-09-30-356.22%
2024-06-30-333.30%
2024-03-31-239.83%
2023-12-31-174.70%
2023-09-30-131.02%
2023-06-30-93.59%
2023-03-31-70.12%
2022-12-31-59.05%
2022-09-30-71.74%
2022-06-30-60.31%
2022-03-31-53.12%
2021-12-31-45.25%
2021-09-30-38.33%
2021-06-30-43.31%
2021-03-31-27.03%
2020-12-31-17.07%

Annual ROE

DateROE
2025-12-31164.71%
2024-12-31-489.14%
2023-12-31-174.70%
2022-12-31-59.05%
2021-12-31-45.25%
2020-12-31-17.07%
2019-12-3153.30%

Similar stocks

Stock NameCountryMarket CapPE Ratio
EXOZYMES INC. (EXOZ)United States$0.058B
ImageneBio, Inc. (IMA)United States$0.056B-1.31
Inmune Bio, Inc. (INMB)United States$0.056B-2.48
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
Tevogen Inc. (TVGN)United States$0.049B
Instil Bio, Inc. (TIL)United States$0.048B-1.73
LeonaBio, Inc. (LONA)United States$0.047B-0.61
BioStem Technologies, Inc. (BSEM)United States$0.069B
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02